Continuous Glucose Monitoring Initiation Within First Year of Type 1 Diabetes Diagnosis Is Associated With Improved Glycemic Outcomes: 7-Year Follow-Up Study
Open accessThe DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To evaluate long-term glycemic outcomes of continuous glucose monitoring (CGM) initiation within the first year of type 1 diabetes diagnosis. RESEARCH DESIGN AND METHODS: Patients with type 1 diabetes (N = 396) were divided into three groups: 1) CGM (CGM use within 1 year of diabetes diagnosis and continued through the study), 2) no-CGM (no CGM use throughout the study), and 3) new-CGM (CGM use after 3 years since diabetes diagnosis). Patients were followed up to 7 years. RESULTS: A1c was significantly lower in the CGM compared with the no-CGM group throughout 7 years of follow-up (least squares mean A1c values: 6 months, 7.3% vs. 8.1%; 1 year, 7.4% vs. 8.6%; 2 years, 7.7% vs. 9.1%; 3 years, 7.6% vs. 9.3%; 4 years, 7.4% vs. 9.6%; 5 years, 7.6% vs. 9.7%; 6 years, 7.5% vs. 10.0%; and 7 years, 7.6% vs. 9.8%; for all, P < 0.001) adjusting for age at diagnosis, sex, and insulin delivery method. CONCLUSIONS: CGM initiation within first year of type 1 diabetes diagnosis results in long-term improvement in A1c.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Integration of continuous glucose monitoring (CGM) into the treatment plan soon after diagnosis improves glycemic outcomes, decreases hypoglycemic events, and improves quality of life for individuals with type 1 diabetes (18-23).”
From 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025 (2025) · cites this paper as [20]
Citations
Cites
Beck, R. W., Riddlesworth, T., Ruedy, K., Ahmann, A., Bergenstal, R., Haller, S., Kollman, C., Kruger, D., McGill, J. B., Polonsky, W., et al. (2017) · JAMA · doi:10.1001/jama.2016.19975 · Cited by 1,185
Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus
The Writing Team for the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group (2002) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.287.19.2563 · Cited by 941
Lind, M., Polonsky, W., Hirsch, I. B., Heise, T., Bolinder, J., Dahlqvist, S., Schwarz, E., Ólafsdóttir, A. F., Frid, A., Wedel, H., et al. (2017) · JAMA · doi:10.1001/jama.2016.19976 · Cited by 705
Pratley, R. E., Kanapka, L. G., Rickels, M. R., Ahmann, A., Aleppo, G., Beck, R., Bhargava, A., Bode, B. W., Carlson, A., Chaytor, N. S., et al. (2020) · JAMA · doi:10.1001/jama.2020.6928 · Cited by 375
Self-citationAleppo, G., Ruedy, K. J., Riddlesworth, T. D., Kruger, D. F., Peters, A. L., Hirsch, I., Bergenstal, R. M., Toschi, E., Ahmann, A. J., Shah, V. N., et al. (2017) · Diabetes Care · doi:10.2337/dc16-2482 · Cited by 329
Self-citationRacial–Ethnic Disparities in Diabetes Technology use Among Young Adults with Type 1 Diabetes
Agarwal, S., Schechter, C., Gonzalez, J., & Long, J. A. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2020.0338 · Cited by 182 · cited 1×
“Disparity in diabetes care and in initiation of diabetes technologies such as insulin pumps and CGM is well known (13,14).”
BackgroundAkturk, H. K., Agarwal, S., Hoffecker, L., & Shah, V. N. (2021) · Diabetes Care · doi:10.2337/dc20-3063 · Cited by 81 · cited 1×
“Disparity in diabetes care and in initiation of diabetes technologies such as insulin pumps and CGM is well known (13,14).”
BackgroundSelf-citationMulinacci, G., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2018.0257 · Cited by 66 · cited 5×
“This is an extension of a previously published study (6).”
BackgroundMethodSelf-citationPatton, S. R., Noser, A. E., Youngkin, E. M., Majidi, S., & Clements, M. A. (2019) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2019.0026 · Cited by 51
Cited by
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Bajaj, M., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s009 · Cited by 728
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gaglia, J. L., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s009 · Cited by 662
Phillip, M., Nimri, R., Bergenstal, R. M., Barnard-Kelly, K., Danne, T., Hovorka, R., Kovatchev, B. P., Messer, L. H., Parkin, C. G., Ambler-Osborn, L., et al. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac022 · Cited by 443
Self-citation7. Diabetes Technology: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s007 · Cited by 348
7. Diabetes Technology: Standards of Care in Diabetes — 2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s007 · Cited by 301
7. Diabetes Technology: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s007 · Cited by 281
9. pharmacologic approaches to glycemic treatment: standards of care in diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s009 · Cited by 263
7. Diabetes Technology: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s007 · Cited by 279
14. Children and Adolescents: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s014 · Cited by 200
14. Children and Adolescents: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s014 · Cited by 173
14. Children and Adolescents: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Hilliard, M. E., Johnson, E. L., Khunti, K., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s014 · Cited by 165
ISPAD Clinical Practice Consensus Guidelines 2022: Diabetes technologies: Glucose monitoring
Tauschmann, M., Forlenza, G., Hood, K., Cardona‐Hernandez, R., Giani, E., Hendrieckx, C., DeSalvo, D. J., Laffel, L. M., Saboo, B., Wheeler, B. J., et al. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13451 · Cited by 100
“initiated in the first year after T1D diagnosis compared to no CGM use or when CGM initiation after the first year.(96)”
Expanding the Role of Continuous Glucose Monitoring in Modern Diabetes Care Beyond Type 1 Disease
Klupa, T., Czupryniak, L., Dzida, G. J., Fichna, P., Jarosz-Chobot, P. A., Gumprecht, J., Myśliwiec, M., Szadkowska, A., Bomba-Opon, D. A., Czajkowski, K., et al. (2023) · Diabetes Therapy · doi:10.1007/s13300-023-01431-3 · Cited by 94
“A second extended study of adults with T1DM started on CGM within 12 months of their diagnosis found that reductions in HbA1c were persistent with CGM use over a 7-year period [26].”
Background14. Children and Adolescents: Standards of Care in Diabetes—2026
Bajaj, M. S., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Early, K. B., ChallaSivaKanaka, S., Echouffo-Tcheugui, J. B., et al. (2025) · Diabetes Care · doi:10.2337/dc26-s014 · Cited by 96
Tauschmann, M., Cardona‐Hernandez, R., DeSalvo, D. J., Hood, K. K., Лаптев, Д. Н., Olinder, A. L., Wheeler, B. J., & Smart, C. E. (2025) · Hormone Research in Paediatrics · doi:10.1159/000543156 · Cited by 82
Burnside, M. J., Williman, J. A., Davies, H. M., Jefferies, C., Paul, R. G., Wheeler, B. J., Wiltshire, E. J., Anderson, Y. C., & de Bock, M. I. (2022) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2022.100644 · Cited by 63
Karakus, K. E., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N. (2023) · Diabetes Care · doi:10.2337/dc23-0495 · Cited by 52
Self-citationDovč, K., Lanzinger, S., Cardona‐Hernandez, R., Tauschmann, M., Marigliano, M., Cherubini, V., Preikša, R. T., Schierloh, U. H. E., Clapin, H. F., Aljaser, F., et al. (2023) · JAMA Network Open · doi:10.1001/jamanetworkopen.2023.0077 · Cited by 56
Griffin, T. P., Gallen, G., Hartnell, S., Crabtree, T. S. J., Holloway, M., Gibb, F. W., Lumb, A. N., Wilmot, E. G., Choudhary, P., & Hussain, S. (2023) · Diabetic Medicine · doi:10.1111/dme.15078 · Cited by 54
Friedman, J. G., Cardona, Z., Szmuilowicz, E. D., & Aleppo, G. (2023) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s374663 · Cited by 60
“001) adjusting for age at diagnosis, sex, and insulin delivery method.(29) Trials evaluating the use of CGM found similar results including such as the case for the REPLACE-BG and IMPACT studies.”
ResultKong, A. P. S., Lim, S. K., Yoo, S.-H., Ji, L., Chen, L., Bao, Y., Yeoh, E. C. K., Chan, S.-P., Wang, C., Mohan, V., et al. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110718 · Cited by 49
Criego, A. B., Carlson, A. L., Brown, S. A., Forlenza, G. P., Bode, B. W., Levy, C. J., Hansen, D. W., Hirsch, I. B., Bergenstal, R. M., Sherr, J. L., et al. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0364 · Cited by 46
Self-citationEffectiveness of Semaglutide and Tirzepatide in Overweight and Obese Adults with Type 1 Diabetes
Snell-Bergeon, J. K., Kaur, G., Renner, D., Akturk, H. K., Beatson, C., & Garg, S. K. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.0328 · Cited by 40
Self-citationAktürk, H. K., Battelino, T., Castañeda, J., Arrieta, A., van den Heuvel, T. R. A., & Cohen, O. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0432 · Cited by 27
Expanding the horizon of continuous glucose monitoring into the future of pediatric medicine
Morales-Dopico, L., & MacLeish, S. A. (2024) · Pediatric Research · doi:10.1038/s41390-024-03573-x · Cited by 25
Benchmarking Diabetes Technology Use Among 21 U.S. Pediatric Diabetes Centers
Prahalad, P., Hardison, H., Odugbesan, O., Lyons, S. K., Alwazeer, M., Neyman, A., Miyazaki, B., Cossen, K., Hsieh, S., Eng, D. S., et al. (2023) · Clinical Diabetes · doi:10.2337/cd23-0052 · Cited by 24
Tecce, N., Cennamo, G., Rinaldi, M., Costagliola, C., & Colao, A. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13030831 · Cited by 25
“A study focused on the real-world use of HCL systems in the U.S. showed that the overall glycemic control achieved with these systems was consistent with the results of pivotal trials [67].”
ResultReed, J., Dong, T., Eaton, E., Friswold, J., Porges, J., Al‐Kindi, S. G., Rajagopalan, S., & Neeland, I. J. (2024) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.15608 · Cited by 22
Akturk, H. K., American Diabetes Association Diabetes Technology Interest Group, Aloi, J., Shah, V. N., Akturk, H. K., McKee, A. M., Ekhlaspour, L., Kim, S., & Everett, E. (2024) · Clinical Diabetes · doi:10.2337/cd23-0080 · Cited by 16
Self-citationAlshannaq, H. A., Cogswell, G., Pollock, R. F., Ahmed, W., Norman, G. J., Lynch, P. M., & Roze, S. (2023) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15158 · Cited by 16
Mann, E. A., Rompicherla, S., Miyazaki, B., Rioles, N. A., Hardison, H., Golden, L., Sarhis, J., Aktürk, H. K., Lee, J. M., DeSalvo, D. J., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0076 · Cited by 15
Aktürk, H. K., Sakamoto, C., Vigers, T., Shah, V. N., & Pyle, L. L. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231200901 · Cited by 14
Self-citationLingen, K., Maahs, D. M., Bellini, N. J., & Isaacs, D. M. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0440 · Cited by 13
Psychosocial Needs for Newly Diagnosed Youth with Type 1 Diabetes and Their Families
Patton, S. R., Maahs, D. M., Prahalad, P., & Clements, M. A. (2022) · Current Diabetes Reports · doi:10.1007/s11892-022-01479-8 · Cited by 15
The Role of Advanced Technologies in Improving Diabetes Outcomes
Marrero, D. G., Parkin, C. G., Aleppo, G., Hirsch, I. B., McGill, J. B., Galindo, R. J., Kruger, D. F., Levy, C. J., Carlson, A. L., & Umpierrez, G. E. (2025) · The American Journal of Managed Care · doi:10.37765/ajmc.2025.89725 · Cited by 13
Emerging Technologies and Therapeutics for Type 1 Diabetes
Aktürk, H. K., & McKee, A. M. (2023) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2023.07.002 · Cited by 10
Gonzalez, J. S., Schneider, S., Hoogendoorn, C. J., Nandoo, L., & Pyatak, E. A. (2025) · Annals of Behavioral Medicine · doi:10.1093/abm/kaaf088 · Cited by 8
Miller, K. M., Bauza, C. E., Kanapka, L. G., Clements, M. A., DeSalvo, D. J., Hood, K. K., Messer, L. H., Sherr, J. L., Bergamo, K., Criego, A. B., et al. (2023) · Pediatric Diabetes · doi:10.1155/2023/6718115 · Cited by 9
Baker, J. C., Cappon, G., Habineza, J. C., Basch, C. H., Mey, S., Malkin-Washeim, D. L., Schuetz, C., Pierre, N. S., Uwingabire, E., Mukamazimpaka, A., et al. (2024) · JMIR Formative Research · doi:10.2196/64585 · Cited by 8
“Improved outcomes have also been shown when a CGM is introduced in the first year after diagnosis with the improvements sustained over time, for as long as 7 years [12].”
Maiorino, M. I., Buzzetti, R., Irace, C., Laviola, L., Napoli, N., Pitocco, D., Esposito, K., & on behalf of LIVE CGM working group (2023) · Endocrine · doi:10.1007/s12020-023-03473-w · Cited by 7
Ehrmann, D., Priesterroth, L., Olesen, B., Haak, T., Kulzer, B., & Hermanns, N. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0333 · Cited by 7
Wong, T.-W. (2023) · Clinical Diabetology · doi:10.5603/dk.a2023.0008 · Cited by 6
Rabbone, I., Savastio, S., Castorani, V., Chiarle, E., Ferrari, A., Pozzi, E., Cavalli, C., & Scaramuzza, A. E. (2025) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2025.0057 · Cited by 5
Erukulapati, R. S., Manikandan, R. M., Jakkidi, L. R., Sathyanarayana, S. O., Ayyagari, U., Aswathiah, S., Nalla, S., Sampath, S. K., Manohar, S. P., Shah, S. C., et al. (2024) · Clinical Diabetology · doi:10.5603/cd.98136 · Cited by 7
“In those who can afford, the use of CGM devices should be considered as soon as diabetes is diagnosed and insulin therapy is initiated [67].”
BackgroundMiyazaki, B., Zeier, T., Banca, R. O. L., Espinoza, J., & Chao, L. C. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241287217 · Cited by 5
Continuous and Intermittent Glucose Monitoring in 2022
Dovč, K., Bode, B. W., & Battelino, T. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.2502 · Cited by 6
Diabetes technology: an update
Prahalad, P., Zaharieva, D. P., & Maahs, D. M. (2026) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgag164 · Cited by 4
Aktürk, H. K. (2024) · Diabetes Care · doi:10.2337/dci24-0002 · Cited by 4
Stedman, L., Williman, J. A., Burnside, M., Davies, H., Jefferies, C., Marsters, B. L., Paul, R. G., Wheeler, B. J., Wiltshire, E. J., & de Bock, M. I. (2024) · New Zealand Medical Journal · doi:10.26635/6965.6470 · Cited by 4
Atiyeh, H. M., Alosta, M. R., Othman, E. H., Khirfan, R., & Hamdan, F. R. (2024) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106241279813 · Cited by 3
“44,45 This technology has become accessible in Jordan over the past few years, but it is still not covered by health insurance.”
Chen, C. W., Durante, A. J., MAYNARD, M. G., Raymond, J. K., Reznik, M., Laffel, L. M., & Agarwal, S. (2025) · Diabetes Spectrum · doi:10.2337/ds24-0061 · Cited by 3
Wallace, C., Rayan, M. N., Folk, S. Y. L., Harris, C., Faulds, E. R., GATTI, T., Duncan, P., Buschur, E., Wyne, K. L., Sobol, T., et al. (2025) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaf169 · Cited by 3
Mayberry, L. S., Nelson, L. A., Bergner, E. M., Raymond, J. K., Tanenbaum, M. L., Jaser, S. S., Wiebe, D. J., Allen, N. A., Berg, C. A., Naranjo, D. M., et al. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241268560 · Cited by 3
Revolutionizing Diabetes Care: From Tech to Therapeutics
Aktürk, H. K., WATERMAN, L. A., & Cobry, E. C. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s580423 · Cited by 2
“The use of CGMs in routine care has significantly improved glycemic control 37,38 and is now recommended as part of standard diabetes management.”
Pasyechko, N. V., Naumova, L. V., Krytskyy, T., & Савченко, І. П. (2024) · INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) · doi:10.22141/2224-0721.19.8.2023.1343 · Cited by 2
Diagnostik, Therapie und Verlaufskontrolle des Typ-1-Diabetes mellitus im Kindes- und Jugendalter
Holder, M., Ziegler, R., Kamrath, C., Lange, K., & Kummer, S. (2024) · Diabetologie und Stoffwechsel · doi:10.1055/a-2374-0813 · Cited by 2
“Die Erweiterung zum AID-System muss gege-ben sein [56, 57, 59, 60].”
Nasser, S. A., Lovre, D., Tajrishi, F. Z., & Ferdinand, K. C. (2025) · Endocrine Research · doi:10.1080/07435800.2025.2577643 · Cited by 2
“38,39 It also lowers complication and hospitalization rates while enhancing patient engagement and self-management across both insulin and noninsulin managed groups.”
Newer Outpatient Diabetes Therapies and Technologies
Kamal, N., Lee, K., & Aleppo, G. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2024.03.002 · Cited by 2
Ziegler, J., Tittel, S. R., Biester, T., Kapellen, T. M., Dost, A., Rochow, N., Barbarini, D. S., Böhle, A., Galler, A., & Holl, R. W. (2024) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2316-0512 · Cited by 1
Lee, H., Yang, M., Kim, H. Y., & Kim, J. (2025) · Annals of Pediatric Endocrinology & Metabolism · doi:10.6065/apem.2550214.107 · Cited by 2
Enhancing Type 2 Diabetes Diagnosis with Evolutionary Algorithms and Machine Learning
Rezaei, P., Saffar, M., Naji, H., Faghih, M. M., & Nouriazar, R. (2025) · National and International Iranian Conference on Biomedical Engineering (ICBME) · doi:10.1109/icbme68496.2025.11392543 · Cited by 1
“The Bat Algorithm, introduced by Yang in 2010, mimics the echolocation behavior of microbats and employs adaptive control of frequency, loudness, and pulse emission rate to maintain a balance between global exploration and local exploitation.”
Karakus, K. E., Snell‐Bergeon, J. K., Mason, E., & Aktürk, H. K. (2024) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241301429 · Cited by 1
Self-citationShah, V. N. (2023) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000820
Self-citationGlucose Monitoring Systems - general rules of use and chances in therapy of type 1 diabetes
Garstka, M., GADOMSKA, A., Kurek, J., GORZYŃSKI, R., DOMINIK, H., Czudy, Z., PAWĘSKA, W., MOLCZYK-SIEŃCZAK, J., RADWAŃSKI, J., & POLATOWSKA, M. (2023) · Journal of Education Health and Sport · doi:10.12775/jehs.2023.26.01.010
“[16] Early implementation of CGM systems can have a positive impact on mean glycemic values and is recommended by the Polish Diabetes Association as the preferred method of self-management in type 1 diabetes.”
MethodImportance of continuous glucose monitoring in the treatment of diabetes mellitus
Moon, S. J., & Lee, W. (2023) · Journal of Korean Medical Association · doi:10.5124/jkma.2023.66.7.432
Yamada, E., Nakajima, Y., Horiguchi, K., Okada, S., & Yamada, M. (2023) · Endocrine Journal · doi:10.1507/endocrj.ej23-0125
Navigating the Complex Management Landscape of Type 1 Diabetes in Clinical Practice
Hasnani, D., & Chavda, V. (2023) · Clinical Diabetology · doi:10.5603/cd.98487
Diabetes Technology and Therapy in the Pediatric Age Group
Maahs, D. M., Prahalad, P., Schweiger, D. Š., & Shalitin, S. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2024.2508
Mit Evidenz zu besseren Blutzuckerwerten
Stiefelhagen, P. (2024) · Info Diabetologie · doi:10.1007/s15034-024-4977-z
Tecnología aplicada a la diabetes
Cebada, A. B., Silva, J. B. Q., Escobar-Morreale, H. F., & Chávez, L. N. (2024) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2024.10.004
Csermely, A., Borella, N. D., Turazzini, A., Pilati, M., Sheiban, S. S., Bonadonna, R. C., Trevisan, R., Trombetta, M., & Lepore, G. (2025) · Journal of Diabetes Science and Technology · doi:10.1177/19322968241308564
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus Typ 1 im Kindes- und Jugendalter
Holder, M., Kamrath, C., Lange, K., Kummer, S., & Ziegler, R. (2025) · Die Diabetologie · doi:10.1007/s11428-024-01279-6
Diagnosis, Therapy and Follow-Up of Type 1 Diabetes Mellitus in Children and Adolescents
Holder, M., Ziegler, R., Kamrath, C., Lange, K., & Kummer, S. (2025) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-2490-5096
Health Technology Assessment of Continuous Glucose Monitoring Systems for Paediatric Patients
Andellini, M., Schiaffini, R., Angelini, M., Pecchia, L., & Ritrovato, M. (2025) · Children · doi:10.3390/children12081088
“…of glycated hemoglobin levels, glycaemic mean, and glycaemic variability in pediatric patients, also confirming the results of Champakanath et al. [47], which demonstrated that initiating CGM use within the first year of T1D diagnosis provides long-term benefits compared to patients who started…”
Intsani, R. T., Setiawan, I. E., Zahrani, F. A., Sulastri, A., Wahdini, R., Dharmansyah, D., & Perdani, A. L. (2025) · Jurnal Kesehatan Tambusai · doi:10.31004/jkt.v6i2.43903
Pharmacologic Therapy for Type 2 Diabetes
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch04
Pharmacologic Therapy for Type 1 Diabetes
(2025) · American Diabetes Association eBooks · doi:10.2337/9781580408462-ch01
Moderna glukosövervakningssystem och hybrid closed loop-insulinpumpar
Tuomaala, A.-K. (2022) · Työväentutkimus Vuosikirja
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Holder, M., Ziegler, R., Kamrath, C., Lange, K., & Kummer, S. (2025) · Diabetologie und Stoffwechsel · doi:10.1055/a-2592-7879
Diagnostik, Therapie und Verlaufskontrolle des Diabetes mellitus im Kindes- und Jugendalter
Holder, M., Kamrath, C., Lange, K., Kummer, S., & Ziegler, R. (2026) · Die Diabetologie · doi:10.1007/s11428-026-01468-5
Dovč, K., Mianowska, B., Boettcher, C., Cardona‐Hernandez, R., Berge, T. V. D., Davis, E. A., Kosteria, I., Marigliano, M., Rami-Merhar, B. M., Scharf, M., et al. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261463841
Yamaoka, T., Sugiyama, T., Kashiwagi, K., Furuno, T., Yamamoto, K., Imai, K., Ihana‐Sugiyama, N., Nishioka, Y., Ohsugi, M., Ueki, K., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113462
Kublin, O., Filipowicz, D., & Stȩpień, M. (2026) · Archives of Medical Science · doi:10.5114/aoms/218227
The role of wearable technology in the management of type 1 diabetes
Sehgal, S. (2024) · Otago University Research Archive (University of Otago)
Holder, M., Ziegler, R., Kamrath, C., Kluge, A., Kummer, S., Lange, K., & Reschke, F. (2026) · Diabetologie und Stoffwechsel · doi:10.1055/a-2874-3708
Metadata
- Authors
- Champakanath, A., Akturk, H. K., Alonso, G. T., Snell-Bergeon, J. K., & Shah, V. N.
- Affiliations
- University of Colorado Anschutz (US)
- Corresponding author
- Shah, Viral N.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2022-01-12
- Volume
- 45
- Issue
- 3
- Pages
- 750-753
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4206020087
- Cited by
- 76
- References
- 15
- Citations by year
- 2026: 6 · 2025: 18 · 2024: 23 · 2023: 23 · 2022: 6
- FWCI
- 13.02
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- Sanofi
- Insulet Corporation
- Dexcom
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 1 diabetes, glycemic control, HbA1c, diabetes management
- MeSH terms
- Blood Glucose, Diabetes Mellitus, Type 1, Follow-Up Studies, Glycated Hemoglobin, Humans, Hypoglycemic Agents, Insulin, Blood Glucose Self-Monitoring
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.